Hikma Pharmaceuticals PLC announces that Peter Speirs will step down as Company Secretary and Hussein Arkhagha, Chief Counsel, will take on the additional role as Company Secretary effective from 15 June 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,973 GBX | -0.25% | -1.94% | +10.29% |
May. 17 | HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum | |
May. 03 | Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+10.29% | 5.58B | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Hikma Pharmaceuticals plc Announces Company Secretary Change